Serum levels of IL-6 and TNF-α correlate with clinicopathological features and patient survival in patients with prostate cancer

por Michalaki, V, Syrigos, K, Charles, P, Waxman, J
Publicado 2004

Serum levels of IL-6 and TNF-α correlate with clinicopathological features and patient survival in patients with prostate cancer

por Michalaki, V, Syrigos, K, Charles, P, Waxman, J
Publicado 2004

Is There a Role of Targeted Agents in the Management of Adrenocortical Cancers?

por Saif, M. W., Fallon, B., Syrigos, K. N.
Publicado 2012

Desmoplasia in Pancreatic Cancer. Can We Fight It?

por Merika, E. E., Syrigos, K. N., Saif, M. W.
Publicado 2012

Biodistribution and pharmacokinetics of(111)In-DTPA-labelled pegylated liposomes in a human tumour xenograft model: implications for novel targeting strategies

por Harrington, K J, Rowlinson-Busza, G, Syrigos, K N, Uster, P S, Abra, R M, Stewart, J S W
Publicado 2000

Influence of tumour size on uptake of(111)In-DTPA-labelled pegylated liposomes in a human tumour xenograft model

por Harrington, K J, Rowlinson-Busza, G, Syrigos, K N, Abra, R M, Uster, P S, Peters, A M, Stewart, J S W
Publicado 2000

Targeted radiosensitisation by pegylated liposome-encapsulated 3′, 5′-O-dipalmitoyl 5-iodo-2′-deoxyuridine in a head and neck cancer xenograft model

por Harrington, K J, Syrigos, K N, Uster, P S, Zetter, A, Lewanski, C R, Gullick, W J, Vile, R G, Stewart, J S W
Publicado 2004

189P Assessment of seroconversion after SARS-CoV2 vaccination in patients with lung cancer

por Trontzas, I.P., Vathiotis, I., Gomatou, G., Grammoustianou, M., Tsamis, I., Anagnostakis, M., Sakka, V., Poulakou, G., Syrigos, K.N., Kotteas, E.A.
Publicado 2022

FOLFOXIRI (folinic acid, 5-fluorouracil, oxaliplatin and irinotecan) vs FOLFIRI (folinic acid, 5-fluorouracil and irinotecan) as first-line treatment in metastatic colorectal cance...

por Souglakos, J, Androulakis, N, Syrigos, K, Polyzos, A, Ziras, N, Athanasiadis, A, Kakolyris, S, Tsousis, S, Kouroussis, Ch, Vamvakas, L, Kalykaki, A, Samonis, G, Mavroudis, D, Georgoulias, V
Publicado 2006

Second-line treatment with irinotecan plus cisplatin vs cisplatin of patients with advanced non-small-cell lung cancer pretreated with taxanes and gemcitabine: a multicenter random...

por Georgoulias, V, Agelidou, A, Syrigos, K, Rapti, A, Agelidou, M, Nikolakopoulos, J, Polyzos, A, Athanasiadis, A, Tselepatiotis, E, Androulakis, N, Kalbakis, K, Samonis, G, Mavroudis, D
Publicado 2005

Irinotecan plus gemcitabine vs irinotecan for the second-line treatment of patients with advanced non-small-cell lung cancer pretreated with docetaxel and cisplatin: a multicentre,...

por Georgoulias, V, Kouroussis, C, Agelidou, A, Boukovinas, I, Palamidas, P, Stavrinidis, E, Polyzos, A, Syrigos, K, Veslemes, M, Toubis, M, Ardavanis, A, Tselepatiotis, E, Vlachonikolis, I
Publicado 2004

Gefitinib (ZD1839, Iressa™) as palliative treatment in recurrent or metastatic head and neck cancer

por Kirby, A M, A'hern, R P, D'ambrosio, C, Tanay, M, Syrigos, K N, Rogers, S J, Box, C, Eccles, S A, Nutting, C M, Harrington, K J
Publicado 2006

A multicenter phase III trial comparing irinotecan-gemcitabine (IG) with gemcitabine (G) monotherapy as first-line treatment in patients with locally advanced or metastatic pancrea...

por Stathopoulos, G P, Syrigos, K, Aravantinos, G, Polyzos, A, Papakotoulas, P, Fountzilas, G, Potamianou, A, Ziras, N, Boukovinas, J, Varthalitis, J, Androulakis, N, Kotsakis, A, Samonis, G, Georgoulias, V
Publicado 2006

Expression of CC chemokine receptor 7 in tonsillar cancer predicts cervical nodal metastasis, systemic relapse and survival

por Pitkin, L, Luangdilok, S, Corbishley, C, Wilson, P O G, Dalton, P, Bray, D, Mady, S, Williamson, P, Odutoye, T, Rhys Evans, P, Syrigos, K N, Nutting, C M, Barbachano, Y, Eccles, S, Harrington, K J
Publicado 2007

1707P CureCancer digital tool in the routine clinical oncology practice facilitates PROs, communicating with HCPs, treatment adherence and “distancing interventions” during COVID-1...

por Galiti, D., Agelaki, S., Karampeazis, A., Linardou, H., Tsoukalas, N., Arvanitou, E., Georgopoulou, E., Vallilas, C., Syrigos, K., Sgourou, S., Kokkali-Zervos, S., Stamatogianni, E., Boutis, A., Christopoulou, A.N., Kontovinis, L., Mala, A., Rigas, G., Saridaki-Zoras, Z., Nicolatou-Galitis, O., Boukovinas, I.
Publicado 2020

Association of the advanced lung cancer inflammation index (ALI) with immune checkpoint inhibitor efficacy in patients with advanced non-small-cell lung cancer

por Mountzios, G., Samantas, E., Senghas, K., Zervas, E., Krisam, J., Samitas, K., Bozorgmehr, F., Kuon, J., Agelaki, S., Baka, S., Athanasiadis, I., Gaissmaier, L., Elshiaty, M., Daniello, L., Christopoulou, A., Pentheroudakis, G., Lianos, E., Linardou, H., Kriegsmann, K., Kosmidis, P., El Shafie, R., Kriegsmann, M., Psyrri, A., Andreadis, C., Fountzilas, E., Heussel, C.-P., Herth, F.J., Winter, H., Emmanouilides, C., Oikonomopoulos, G., Meister, M., Muley, T., Bischoff, H., Saridaki, Z., Razis, E., Perdikouri, E.-I., Stenzinger, A., Boukovinas, I., Reck, M., Syrigos, K., Thomas, M., Christopoulos, P.
Publicado 2021